Takara Bio Commences Clinical Study For Esophageal Cancer Gene Therapy
This article was originally published in PharmAsia News
Executive Summary
Takara Bio and Mie University started the first clinical study of T-cell receptor gene therapy on patients with esophageal cancer Aug. 18